MAPT and Alzheimer disease: Specifically in AD, fisetin reduces hyperphosphorylated tau and autophagy activation.[261, 262] The study revealed that fisetin inhibits the aggregation of the tau fragment K18 and induces its depolymerization in vitro, as demonstrated by ThT fluorescence assays and transmission electron microscopy.